Dive Into Psychedelic Therapy: CPA Fall Symposium Early Bird Extended |
| Registration Type | Early Bird (8/28 - 10/4) | Regular (10/5 - 11/8) |
|---|---|---|
| Member | $165 | $185 |
| Non-Member | $255 | $285 |
| Student | $65 | $75 |
Why Attend?
This day-long symposium brings together leading experts to discuss the latest research, best practices, and ethical considerations in the field of psychedelic-assisted therapy. Whether you’re a seasoned professional or new to this area, you’ll gain invaluable insights and practical knowledge.
Continuing Education
Gain 7 hours of continuing education available for both in-person and virtual attendees.
Psychedelic-Assisted Psychotherapy: Pharmacologic, Psychotherapeutic, and Practical Considerations - 9:00 - 9:55 AM
Explore the pharmacology of psychedelics, criteria for patient selection, and the preparation and integration necessary for successful psychedelic-assisted psychotherapy (PAP). This session, led by Dr. Randy Buzan and Dr. Susan Frederick, emphasizes the importance of good preparation and integration for effective outcomes.
How Psychedelics Affect the Brain: Key Findings & Debates - 10:00 - 10:55 AM
Join Dr. Maneesh Girn as he delves into the neuroscience of psychedelics, examining how they alter brain function and promote therapeutic benefits. Gain a comprehensive overview of key discoveries and controversies in the field, including neuroplasticity and its role in therapy.
Legal & Regulatory Landscape Session - 11:00 AM - 12:30 PM
Ethics Session: Psychedelic Ethics—Exploring the Shadow and Embracing Harm Reduction - 1:30 - 2:55 PM
Dori G Lewis and Shoshana Aal tackle the ethical complexities in psychedelic facilitation, discussing harm reduction strategies and community-driven approaches to avoid ethical missteps. Learn how indigenous practices can guide ethical facilitation in this rapidly evolving field.
Psilocybin-Assisted Psychotherapy for Those with Advanced Cancer - 3:00 - 4:00 PM
Kristin Kilbourn presents findings from a clinical trial on psilocybin-assisted psychotherapy for cancer patients, highlighting its potential to alleviate distress and improve quality of life. Understand the challenges and benefits of this innovative therapeutic approach
Disrupted Reconsolidation of Emotional Memory in Psychedelic-Assisted Psychotherapy - 4:00 - 5:00 PM
Explore the therapeutic mechanisms behind psychedelic-assisted therapy with Dr. Jim Grigsby and Dr. Shandra M. Brown Levey. Learn how psychedelics can interfere with reconsolidation of emotional memory, providing a promising avenue for treating PTSD and trauma-related conditions.